NEWS

News Articles

Biden makes all adults eligible for a vaccine on April 19

April 6, 2021

President Joe Biden announced Tuesday that he’s bumping up his deadline by two weeks for states to make all adults in the U.S. eligible for coronavirus vaccines. But even as he expressed optimism about the pace of vaccinations, he warned Americans that the nation is not yet out of the woods when it comes to…

Read More

Carr And Georgia Department Of Public Health Warn Of COVID-19 Vaccine Scams

April 5, 2021

Attorney General Chris Carr and the Georgia Department of Health are again warning Georgians that scammers have been trying to exploit the vaccine rollout by calling, texting or emailing consumers asking for payment for the promise of getting the vaccine, scheduling an appointment or getting on the waiting list. “Scam artists are attempting to take…

Read More

CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune Globulin Medicine

April 2, 2021

Phase 3 Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) Clinical Trial Sponsored and Funded by the National Institute of Allergy and Infectious Diseases (NIAID), Part of the National Institutes of Health (NIH), Did Not Meet Its Endpoints to Show Efficacy in Adults Hospitalized With COVID-19 OSAKA, Japan and KING OF PRUSSIA, Pa., USA – April 2, 2021  – The…

Read More

Quest Diagnostics trades remaining stake in Q2 Solutions to IQVIA for $760M

April 1, 2021

Nearly six years after launching a joint venture with IQVIA’s contract research progenitor, Quintiles, Quest Diagnostics is handing over the remainder of its minority share in return for $760 million in cash. The two companies formed Q2 Solutions in 2015 to provide global biopharma companies with the lab tests needed to run clinical trials and get their…

Read More

GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent

April 1, 2021

Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide Atlanta, GA – (NewMediaWire) – April 01, 2021 – GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance…

Read More

Blink President Pens Letter to Biden Administration in Support of Ongoing COVID Testing

April 1, 2021

Blink Science President Eric Doherty sent a letter to President Biden yesterday in the wake of the announcement that a fourth wave of the coronavirus is taking hold in the US. “Despite extraordinary efforts to get vaccinations into the arms of our citizens, a fourth wave of coronavirus infections has begun, with the CDC reporting an average of 65,000…

Read More